Chemotherapy resistance and oncogene expression in non–small cell lung cancer
Authors:
- Thomas A. D‘aMatoTDThomas A. D‘aMato
- Rodney J. LandreneauRLRodney J. Landreneau
- William RickettsWRWilliam Ricketts
- Weidong HuangWHWeidong Huang
- Ricardo ParkerRPRicardo Parker
- Eugene MechetnerEMEugene Mechetner
- Ing-Ru YuIYIng-Ru Yu
- James D. LuketichJLJames D. Luketich
- 1 February 2007
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 133 (2) , 352-363
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prevalence of In Vitro Extreme Chemotherapy Resistance in Resected Nonsmall-Cell Lung CancerThe Annals of Thoracic Surgery, 2006
- ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist AssociationJournal of Clinical Oncology, 2005
- American Society of Clinical Oncology Technology Assessment: Chemotherapy Sensitivity and Resistance AssaysJournal of Clinical Oncology, 2004
- Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633Journal of Clinical Oncology, 2004
- Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598Journal of Clinical Oncology, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay–guided chemotherapyAmerican Journal of Obstetrics and Gynecology, 2003
- Association between in Vitro Platinum Resistance in the EDR Assay and Clinical Outcomes for Ovarian Cancer PatientsGynecologic Oncology, 2002
- Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance AssayBreast Cancer Research and Treatment, 2001
- Consensus review of the clinical utility of DNA cytometry in carcinoma of the breastBreast Cancer Research and Treatment, 1993